- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04323267
Digital Home-Exercise Therapy Application For Patients With Non-Surgical Knee Injuries
May 27, 2020 updated by: Jacob L. Sellon, M.D., Mayo Clinic
Efficacy of Digital Home-Exercise Therapy Application For Patients With Non-Surgical Knee Injuries: A Randomized, Controlled Trial
Knee pain is one of the most prevalent musculoskeletal disorders in the United States.
Conservative treatments generally consist of pharmacological agents and physical therapy.
Unfortunately, such conservative care is often mismanaged, and little data is collected on clinical outcomes.
The proposed investigation utilizes a novel and state-of-the-art mobile application (DETP) to guide an at-home exercise therapy program for non-operative knee pain.
The purpose of this study is conducting a single-blind randomized, controlled, superiority study to compare the DETP to conventional physical therapy (PT).
The investigators will seek to determine improvement in pain and function in PROMIS measures as the primary outcome.
The investigators will also evaluate satisfaction with the application as a secondary outcome.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-75, inclusive.
- Diagnosis of knee injury. For participants enrolled from the Mayo healthcare system database, knee injury identified from electronic medical records.
- Pain Numerical Rating Scale score of 4 or greater on a 0-10 scale (0 = no pain, 10 = pain).
- Participants must be diagnosed with a knee injury and the next step of care is either a home exercise program or external physical therapy ordered at the academic center.
- Prescribed external physical therapy (i.e., therapy not completed at Mayo Clinic in Rochester/Minneapolis).
Exclusion Criteria:
- No access to android or iPhone smartphone
- BMI greater than or equal to 35
- Previously completed series of physical therapy visits for knee injury within the past 12 months for the same injury (received one introduction PT session as seen in executive program will not be considered an exclusion).
- Recommended by a physician for consideration of total knee replacement.
- Diagnosis of rheumatoid arthritis, fibromyalgia, gout in the knee, or other systemic rheumatic disease.
- Hospitalization for a stroke, heart attack, heart failure, or had surgery for blocked arteries in the past 12 months.
- Total joint replacement knee surgery, bucket-handle meniscus tear, ACL tear, or other knee surgery in the past 12 months.
- Unable to speak English.
- Active diagnosis of psychosis.
- Fall history deemed by a physician to impose risk for potential injury with participation in a home-based exercise program.
- Severely impaired hearing or speech.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital Home Exercise Program
Limber Digital Application Device (3 x a week for 8 weeks)
|
A mobile application was recently developed to address these needs.
The application provides evidence-based, symptom specific home-exercise video programs for MSK conditions, as well as clinically-validated outcome measures for tracking progress.
|
|
Active Comparator: Physical therapy
Therapy prescription 2 x a week for 8 weeks (specified by physician)
|
Therapy prescription 2 x a week for 8 weeks (specified by physician)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS Pain Score
Time Frame: 8 weeks
|
Pain is measured by 0-100.
0 = no pain and 100 = very high pain
|
8 weeks
|
|
PROMIS Physical Function CAT
Time Frame: 8 weeks
|
Function is measured by 0-100.
0= no function and 100 = high function
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject Satisfaction Questions
Time Frame: 8 weeks
|
Satisfaction questions
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
May 15, 2020
Study Completion (Actual)
May 15, 2020
Study Registration Dates
First Submitted
March 23, 2020
First Submitted That Met QC Criteria
March 24, 2020
First Posted (Actual)
March 26, 2020
Study Record Updates
Last Update Posted (Actual)
May 29, 2020
Last Update Submitted That Met QC Criteria
May 27, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-007031
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.